Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase NA 2Phase 1/2 1

Status

Unknown 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cytarabine 166Cyclophosphamide 110Daunorubicin 88Methotrexate 83Etoposide 66Vincristine 63Mercaptopurine 55Rituximab 54Dexamethasone 54venetoclax 50fludarabine 47Doxorubicin 46Azacitidine 46Idarubicin 45Asparaginase 42Imatinib Mesylate 41Prednisone 39pegaspargase 37Thioguanine 36Radiotherapy 35Mitoxantrone 35Busulfan 31Peripheral Blood Stem Cell Transplantation 25Leucovorin 25Bendamustine Hydrochloride 25fludarabine phosphate 24Filgrastim 24obinutuzumab 23nilotinib 23Granulocyte Colony-Stimulating Factor 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Aclarubicin × Other hematologic neoplasm × Clear all
NCT07541755 2026-04-21

PD1-VEN-CAG

Fujian Medical University Union Hospital

Phase 3 Active not recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05382390 2022-05-19

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

Shengjing Hospital

Phase 3 Unknown
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown
315 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04083911 2019-09-10

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
50 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡